CN101843870B - Chinese medicament for treating diabetic acro-necrosis - Google Patents

Chinese medicament for treating diabetic acro-necrosis Download PDF

Info

Publication number
CN101843870B
CN101843870B CN2009102383553A CN200910238355A CN101843870B CN 101843870 B CN101843870 B CN 101843870B CN 2009102383553 A CN2009102383553 A CN 2009102383553A CN 200910238355 A CN200910238355 A CN 200910238355A CN 101843870 B CN101843870 B CN 101843870B
Authority
CN
China
Prior art keywords
chinese medicine
chinese
chinese medicament
necrosis
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102383553A
Other languages
Chinese (zh)
Other versions
CN101843870A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tian Runsheng
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102383553A priority Critical patent/CN101843870B/en
Publication of CN101843870A publication Critical patent/CN101843870A/en
Application granted granted Critical
Publication of CN101843870B publication Critical patent/CN101843870B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating diabetic acro-necrosis, and belongs to the field of Chinese medicaments for treating surgery diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: virgate wormwood herb, root of rehmannia, lucid ganoderma, oriental waterplantain rhizome, dandelion, radix pseudo-ginseng, Chinese angelica, coix seed and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, clearing heat and promoting diuresis, and promoting circulation of blood and dispersing swelling, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

一种治疗糖尿病肢端坏死的中药A kind of traditional Chinese medicine for treating diabetic extremity necrosis

技术领域technical field

本发明属于治疗外科病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating surgical diseases.

背景技术Background technique

目前用于治疗糖尿病肢端坏死的西药和中药,存在一些明显的不足:一是效果不明显,二是见效较迟缓,大量患者面对糖尿病肢端坏死束手无策,患肢久治不愈,不断恶化,最后不得不做截肢手术处理。The western and traditional Chinese medicines currently used to treat diabetic extremity necrosis have some obvious deficiencies: first, the effect is not obvious; Amputation was not performed.

针对以上提出的问题,本发明提供一种治疗糖尿病肢端坏死的中药,它能解决以往此类中药治疗中效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for the treatment of diabetic extremity necrosis, which can solve the problem that the effect of this type of traditional Chinese medicine is not obvious enough in the past, and the effect is relatively slow. Exactly, the advantage of quicker effect.

发明内容Contents of the invention

本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:

1、一种治疗糖尿病肢端坏死的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of diabetic extremity necrosis, adopts Chinese medicine raw material to prepare, and formula is (by weight):

茵陈5--40份    生地5--40份       灵芝2--12份Yinchen 5--40 parts Shengdi 5--40 parts Ganoderma lucidum 2--12 parts

泽泻4--30份    蒲公英4--30份     三七3--20份Alisma 4--30 parts Dandelion 4--30 parts Panax notoginseng 3--20 parts

当归4--30份    薏苡仁5--40份Angelica 4--30 parts Coix seed 5--40 parts

这种治疗糖尿病肢端坏死的中药是由下列方法制成的:This traditional Chinese medicine for treating diabetic extremity necrosis is made by the following methods:

(1)按上述重量比,将茵陈、生地、泽泻、蒲公英、当归、薏苡仁常规水提取工艺提取,制成浸膏细粉;(1) According to the above weight ratio, extract capillary wormwood, habitat, Alisma, dandelion, angelica, coix seed with conventional water extraction process to make extract powder;

(2)按上述重量比,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.

本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。本方主治糖尿病肢端坏死,属湿热下注夹瘀者。方中灵芝、生地扶正培本,益气养血,补益五脏,增强机体免疫力;当归、三七补血养血,活血化瘀止痛;茵陈、薏苡仁清热利湿,行血消肿;佐以蒲公英、泽泻助祛湿清热之力。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀,清热利湿,行血消肿之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. This prescription is mainly used to treat diabetic extremity necrosis, which belongs to the case of damp-heat betting and stasis. In the prescription, Ganoderma lucidum and Shengdi Fuzheng Peiben can nourish qi and blood, nourish the five internal organs, and enhance the body's immunity; Use dandelion and Alisma to help dispel dampness and clear away heat. All the medicines are compatible and complement each other. They play the role of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, clearing away heat and dampness, promoting blood circulation and reducing swelling. The effect is good and quick. advantage.

具体实施方式Detailed ways

通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:

1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):

茵陈100克    生地100克     灵芝40克Capsicum chen 100g Rehmannia 100g Ganoderma lucidum 40g

泽泻80克     蒲公英80克    三七60克Alisma 80g Dandelion 80g Panax notoginseng 60g

当归80克     薏苡仁100克Angelica 80g Coix seed 100g

按规定重量,用常规水提取工艺将茵陈、生地、泽泻、蒲公英、当归、薏苡仁提取,制成浸膏细粉162克,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊935粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, extract capillary wormwood, habitat, Alisma, dandelion, angelica, and coix seed by conventional water extraction process to make 162 grams of extract powder, and grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, and mix with the above extract The fine powder is mixed, stirred evenly, made into fine particles, packed into No. 0 capsules, and made into 935 Chinese medicine capsules, each capsule containing 0.28 grams of Chinese medicine fine powder and extract.

2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):

茵陈200克    生地200克      灵芝60克Capsicum chen 200g Rehmannia 200g Ganoderma lucidum 60g

泽泻160克    蒲公英160克    三七100克Alisma 160g Dandelion 160g Panax notoginseng 100g

当归160克    薏苡仁200克Angelica 160g Coix seed 200g

按上述同样的方法,制成中药胶囊1728粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1728 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):

茵陈400克    生地400克     灵芝120克Capsicum chen 400g Rehmannia 400g Ganoderma lucidum 120g

泽泻300克    蒲公英300克   三七200克Alisma 300g Dandelion 300g Sanqi 200g

当归300克    薏苡仁400克Angelica 300g Coix seed 400g

按上述同样的方法,制成中药胶囊3392粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 3392 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.

4、取以下配方(按重量比):4. Take the following formula (by weight):

茵陈9份    生地9份      灵芝3份Capsicum 9 parts , Rehmannia 9 parts , Ganoderma lucidum 3 parts

泽泻7份    蒲公英7份    三七4份Alisma 7 parts Dandelion 7 parts Panax notoginseng 4 parts

当归7份    薏苡仁9份Angelica 7 parts Coix seed 9 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

5、取以下配方(按重量比):5. Take the following formula (by weight):

茵陈30份    生地30份      灵芝8份Capsicum chen 30 parts Rehmannia 30 parts Ganoderma lucidum 8 parts

泽泻20份    蒲公英20份    三七15份Alisma 20 parts Dandelion 20 parts Panax notoginseng 15 parts

当归20份    薏苡仁30份Angelica 20 parts Coix seed 30 parts

按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.

临床资料:clinical information:

本发明以中医糖尿病肢端坏死为例,经7例临床观察。选择中医诊断糖尿病肢端坏死为标准:糖尿病患者形体消瘦,肢软乏力;患肢发凉,血液循环不畅;肌肉萎缩;下肢脉搏微弱,间歇性跛行;腿脚皮肤发红、发黑、发紫,组织坏死;肢体麻木,患肢肢端疼痛;患肢肢端溃疡、溃烂,流血流脓,久不愈合。如上症状,即可确诊。在确诊观察的对象中,男性4例,女性3例,无其它严重疾病,年龄为47岁-78岁,平均年龄65岁。The present invention takes diabetic extremity necrosis in traditional Chinese medicine as an example, through clinical observation of 7 cases. TCM diagnosis of diabetic extremity necrosis is selected as the standard: diabetic patients are thin and weak, with weak limbs; cold limbs, poor blood circulation; muscle atrophy; weak pulse of lower limbs, intermittent claudication; red, black, and purple skin of legs and feet , tissue necrosis; limb numbness, pain in the extremity of the affected extremity; ulceration, ulceration, bleeding and pus in the extremity of the affected extremity, which will not heal for a long time. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 4 males and 3 females, without other serious diseases, aged from 47 to 78 years old, with an average age of 65 years old.

疗效判定:Judgment of curative effect:

1、显效:体质增强,身上有劲;肢体温暖,发凉消失;皮肤颜色由黑紫逐步变白(正常皮肤颜色),血液循环明显改善;患肢麻木、肢端疼痛明显减轻;肢端溃烂缓解、愈合。1. Significant effect: Physical fitness is enhanced, body is strong; limbs are warm, and coldness disappears; skin color gradually turns from black to white (normal skin color), blood circulation is significantly improved; numbness of affected limbs, pain in extremities are significantly relieved; extremity ulceration is relieved ,heal.

2、有效:体质增强,身上有劲,肢体温暖,血液循环改善;肢体麻木、疼痛有所缓解。2. Effective: Physical fitness is enhanced, body is strong, limbs are warm, blood circulation is improved; limb numbness and pain are relieved.

3、无效:病症无变化。3. Ineffective: no change in symptoms.

临床实验时,除降糖药物以外,停服其它药物和保健营养品。服用本发明中药胶囊,观察6个月,为一个疗程。服用方法:每日2次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,1个月后症状即有缓解,服用6个月后,症状明显改善。临床实验的7人中,显效3人,有效3人,无效1人,总有效率85.7%。During clinical trials, except for hypoglycemic drugs, stop taking other drugs and health nutrition products. Take Chinese medicine capsule of the present invention, observe 6 months, be a course of treatment. Dosing method: 2 times a day, 4 capsules each time, each capsule contains 0.28 grams of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 1 month, and after 6 months of taking, Symptoms improved significantly. Among the 7 people in the clinical trial, 3 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 85.7%.

Claims (1)

1. a Chinese medicine for the treatment of acromegaly necrosis diabetes adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Artemisiae Scopariae 5-40 part Radix Rehmanniae 5-40 part Ganoderma 2-12 part
Rhizoma Alismatis 4-30 part Herba Taraxaci 4-30 part Radix Notoginseng 3-20 part
Radix Angelicae Sinensis 4-30 part Semen Coicis 5-40 part
The Chinese medicine of this treatment acromegaly necrosis diabetes is made by following method:
(1) by above-mentioned weight ratio, Herba Artemisiae Scopariae, the Radix Rehmanniae, Rhizoma Alismatis, Herba Taraxaci, Radix Angelicae Sinensis, the conventional water extraction process of Semen Coicis are extracted, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009102383553A 2009-11-25 2009-11-25 Chinese medicament for treating diabetic acro-necrosis Expired - Fee Related CN101843870B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102383553A CN101843870B (en) 2009-11-25 2009-11-25 Chinese medicament for treating diabetic acro-necrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102383553A CN101843870B (en) 2009-11-25 2009-11-25 Chinese medicament for treating diabetic acro-necrosis

Publications (2)

Publication Number Publication Date
CN101843870A CN101843870A (en) 2010-09-29
CN101843870B true CN101843870B (en) 2011-07-20

Family

ID=42768809

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102383553A Expired - Fee Related CN101843870B (en) 2009-11-25 2009-11-25 Chinese medicament for treating diabetic acro-necrosis

Country Status (1)

Country Link
CN (1) CN101843870B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101390993B (en) * 2007-09-21 2011-04-27 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic foot

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101390993B (en) * 2007-09-21 2011-04-27 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating diabetic foot

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
文小敏等.糖尿病足中医药诊疗概况.《四川中医》.2000,第18卷(第03期), *

Also Published As

Publication number Publication date
CN101843870A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843699B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843789A (en) Chinese medicament for treating gout
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN102389547A (en) Traditional Chinese medicine for treating diabetic foot
CN101954024A (en) Traditional Chinese medicament for treating diabetic foot
CN101843738A (en) Chinese medicament for treating diabetic feet
CN101843870B (en) Chinese medicament for treating diabetic acro-necrosis
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN102139076A (en) Traditional Chinese medicine for treating diabetic foot
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101530479B (en) Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy
CN101843717B (en) Chinese medicament for treating coronary disease
CN101850078B (en) Chinese medicament for treating chronic nephritis
CN101843741A (en) Chinese medicament for treating femoral head necrosis
CN101843715A (en) Chinese medicament for treating diabetic feet
CN101537068B (en) Chinese medicine for treating angina
CN102018765A (en) Traditional Chinese medicine for treating diabetic acromelic gangrene
CN101843871B (en) Chinese medicament for treating diabetic acro-necrosis
CN101843864A (en) Chinese medicament for treating diabetic acro-necrosis
CN101843802A (en) Chinese medicament for treating diabetic acro-necrosis
CN101843695B (en) Chinese medicament for treating chronic kidney failure
CN101961471A (en) Traditional Chinese medicine for treating diabetic foot
CN101843865A (en) Chinese medicament for treating diabetic acro-necrosis
CN102380067A (en) Traditional Chinese medicine for treating diabetic foot

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: LIU XINZHUANG

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20150722

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150722

Address after: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102

Patentee after: Liu Xinzhuang

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160322

Address after: 030006 Shanxi province Taiyuan city dock Xiaodian District in South Lihua court 13 Building 2 Room 302

Patentee after: Tian Runsheng

Address before: 100040 Beijing city Shijingshan District double Jinyuan District 16 Building 2 unit 1102

Patentee before: Liu Xinzhuang

DD01 Delivery of document by public notice

Addressee: Tian Runsheng

Document name: Notification of Passing Examination on Formalities

DD01 Delivery of document by public notice

Addressee: Tian Runsheng

Document name: Notification to Pay the Fees

DD01 Delivery of document by public notice
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110720

Termination date: 20171125